BioThrust
PrivateLast Round
Grant
Feb 17, 2025
Total Funding Raised
$2.81M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioThrust operates in Healthcare & Life Sciences and is based in Aachen. Its latest recorded funding round was a Grant round in February 2025.
BioThrust is a biotechnology company that develops bioreactor technologies for scalable cell therapy manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioThrust Comparables
Compare BioThrust with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Limula | 83% | |
| Aglaris | 83% | |
| Scinus Cell Expansion | 81% |
For institutional investors. Book with your work email.
BioThrust Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2025 | ||||
| Seed | Jan 25, 2024 | ||||
| Grant | Apr 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioThrust Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Freigeist Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
Open roles increased from 0 to 8, representing 26% of headcount.
- Oct 15, 2025
Grew 22% QoQ, from 23 to 28 employees.
For institutional investors. Book with your work email.
BioThrust Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioThrust's valuation, stock price, and market status.
Is BioThrust a public or private company?
BioThrust is a private company.
What is the current stock price of BioThrust?
BioThrust is a private company, so its shares have no public market price. Caplight tracks BioThrust's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioThrust worth (valuation)?
Valuation information for BioThrust is not publicly available.
Can I buy BioThrust stock?
BioThrust shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioThrust's last funding round?
BioThrust's most recent funding round was Grant on February 17, 2025.
Who are the main investors in BioThrust?
Key investors in BioThrust include Freigeist Capital.
Will BioThrust IPO soon?
No public IPO plans have been announced for BioThrust.
How can I track BioThrust secondary market activity?
Caplight tracks bids, offers, and trades in BioThrust's shares on secondary markets.